Status:
COMPLETED
Effectiveness of Two Approved Drugs in Lowering High Cholesterol (0733-224)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
21-65 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of two approved drugs in lowering high cholesterol when taken together, compared to taking only one of the drugs.
Detailed Description
The duration of treatment is 12 weeks.
Eligibility Criteria
Inclusion
- Elevated cholesterol level
Exclusion
- Liver disease
- Known allergies to study drugs
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 4 2003
Estimated Enrollment :
571 Patients enrolled
Trial Details
Trial ID
NCT00092157
Start Date
May 1 2002
End Date
March 4 2003
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.